Recall: D-0205-2024

Class II - Potentially Harmful

Class IIClassification

2023-12-11Initiated

OngoingStatus

Legacy Pharmaceutical PackaginFirm

Product

Sertraline Tablets, USP 100 mg, 30 tablets per bottle, Distributed by: Wal-Mart, Bentonville, AR 72716, Manufactured for: Cipla USA, Inc., Warren, NJ 07059, Packaged by: Legacy Pharmaceutical Packaging LLC., Earth City, MO 63045, NDC# 68645-523-54

Reason

CGMP Deviations: Inadequate line clearance which may result in a potential comingling of product.

Distribution

CA and AR

Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.